Speckle Tracking Echocardiography for the Prediction of Weaning Failure
Condition(s) studied
Investigational drug(s) / intervention(s)
echocardiography: Speckle tracking echocardiography
Study summary
Deciding the optimal timing for extubation in patients who are mechanically ventilated can be challenging, and traditional weaning predictor tools are not accurate. Recent studies suggest that isolated sonographic assessment of the respiratory and cardiac function (ie diastolic function and filling pressure), in mechanically ventilated patients may assist in identifying patients at risk of weaning failure. Recently, the association of conventional echocardiography and lung ultrasound showed promising results for the prediction of post extubation distress. Speckle Tracking is an emerging tool in intensive care medicine that has never been investiguated for the prediction of weaning failure. It could early detects diastolic dysfunction and and elevated filling pressure. Of more, speckle tracking is known to be less operator dependant. The main objective of our study is to evaluate the diagnosis accuracy of speckle tracking echocardiography performed during a weaning trial to predict weaning failure. The secondary objectives are to assess the diagnosis accuracy of combined heart and lung ultrasound to predict weaning failure.
Eligibility
Primary outcome measure(s)
- lung and heart ultrasounds — Just before and during the weaning trial
Area under the receiver operator characteristic curve (AUC) of global longitudinal strain and strain rate variations (before and during a weaning trial) to predict weaning failure.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Assistance Publique Hôpitaux de Marseille | Marseille | France | Recruiting |
More Assistance Publique Hopitaux De Marseille trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT03657524 on ClinicalTrials.gov ↗ ← All trials in France